RESOURCES - PRESS RELEASES
RevTek Capital’s resources reflect our commitment to supporting innovative companies. Our experts provide professional guidance to navigate the funding process efficiently to build value and growth.
Press Releases
Cloud Dentistry Closes Second Financing Round with RevTek Capital
Cloud Dentistry, the largest network of dental professionals actively seeking permanent and temporary work, is entering an exciting new chapter of growth with financing from RevTek Capital, a leading capital provider for innovative and growing companies.
Fintech Studios™ Closes Fifth Financing Round with RevTek Capital
FinTech Studios™, a leader in AI-driven market intelligence for financial institutions, has closed its fifth financing round with RevTek Capital. The funding will accelerate global expansion and empower FinTech Studios™ to grow its sales, product, and engineering teams. RevTek Capital’s support underscores the strategic value of FinTech Studios’™ platform, which delivers real-time insights from millions of curated sources in 49 languages. Together, the two companies are advancing innovation in AI-powered market and risk intelligence.
Previon Closes a Second Financing Round with RevTek Capital
Previon, a leader in healthcare communication and diagnostic solutions, has closed a second financing round with RevTek Capital. This strategic funding accelerates Previon’s nationwide expansion and innovation in self-service communication tools and at-home diagnostic kit services. With a 30-year legacy in healthcare support, Previon continues to streamline patient engagement and compliance for major care providers.
PaxeraHealth Closes Fourth Funding Round with RevTek Capital
Paxera Health, a leader in AI medical imaging, announces a successful financing round with RevTek Capital to accelerate growth and enhance healthcare solutions. This partnership will enable Paxera to further automate workflows and improve patient care, driving advancements in clinical outcomes for healthcare providers.
Apex Biologix Closes a Strategic Financing Round with RevTek Capital
Apex Biologix, a pioneer in regenerative medicine, has closed a strategic financing round with RevTek Capital to support its rapid growth and expand its suite of FDA-cleared solutions, including the groundbreaking XCELL PRP System. With this funding, Apex will scale its transformative technologies and empower more physicians across the U.S. RevTek’s investment reflects a shared vision for innovation, growth, and impact in healthcare.
ORIGO Closes a Strategic Financing Round with RevTek Capital
In a significant move for its growth strategy, Origo has successfully closed financing with RevTek Capital. This partnership aims to bolster Origo’s market presence and unlock new opportunities for innovation and expansion.
Nice Healthcare Closes Second Financing Round with RevTek Capital
Phoenix, AZ — RevTek Capital, a leading debt funding source for innovative companies, is proud to announce its recent support and collaboration with Nice Healthcare, a dedicated organization with a mission to assist employees and their families in receiving excellent care every day as needed, virtually and in their homes. This partnership represents RevTek Capital’s commitment to supporting organizations that profoundly impact the lives of employees and their families.
CUDDLY Closes a Strategic Financing Round with RevTek Capital
CUDDLY has successfully closed a financing deal with RevTek Capital, marking a significant step in its mission to drive innovation and expand its market presence. This partnership is set to bolster CUDDLY’s capabilities and accelerate its growth trajectory in the competitive tech landscape.
Popular Articles more...
Top 10 SaaS Trends: 2020 Edition
Software as a Service (SaaS) is one of the fastest growing industries today with little sign of slowing down. Companies and business owners alike rely on these services to keep their staff
Increased Demand for Collaboration Software: Powering the Future of Remote and Hybrid Work
Discover how remote and hybrid work models are driving demand for collaboration software tools. Learn how SaaS innovations and RevTek Capital are shaping this evolution.
Newsletter – Feb ’24
Newsletter Feb ’24
It is always exciting! There are always new things happening with talented people innovating and creating value for customers and their businesses. It is fun and rewarding to
Newsletter – Dec 2024
This month for RevTek Capital’s December Newsletter, we’re celebrating the holiday season with gratitude for our incredible clients and partners who inspire us daily. We’re thrilled to announce that Previon, a leader
We devote the time to understand your accomplishments, circumstances, and opportunities to create a customized debt funding structure to accelerate your growth.
